You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Correlating TCR diversity to immune reconstitution after cord blood transplant
SBC: ADAPTIVE BIOTECHNOLOGIES CORPORATION Topic: NHLBIDESCRIPTION (provided by applicant): Many patients requiring stem cell transplantation for hematological malignancies are unable to find a suitable HLA-matched sibling or unrelated donor. Transplants using stem cells from umbilical cord blood provide an alternative for these patients, allowing transplantation to proceed with less stringent HLA-matching requirements. Unfortunately, in addition to t ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Tau Protein Aggregation Inhibitors for Tauopathies
SBC: PROTEOTECH, INC. Topic: NIADESCRIPTION (provided by applicant): Alzheimer's disease (AD) is characterized by brain amyloid plaques consisting of insoluble beta-amyloid protein (A?), and neurofibrillary tangles (NFTs) containing aggregated tau protein. AD drug discovery efforts havebeen largely focused on reducing brain A? levels, with much less emphasis on tau-directed strategies. ProteoTech Inc. has developed a number ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Automated 3D quantitative analysis of dendritic spines imaged with light microsco
SBC: MICROBRIGHTFIELD, LLC Topic: NIMHDESCRIPTION provided by applicant In this Lab to Marketplace proposal we aim to develop the MBF SpineStudio software incorporating the innovative laboratory based NeuronStudio software created at the Mount Sinai School of Medicine Our SpineStudio software will enable automated detection reconstruction and morphological classification of the structural analysis of dendritic spines By creating this ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Reducing Complement Inhibition to Treat Leukemia and Lymphoma
SBC: PAI LIFE SCIENCES INC Topic: NCIDESCRIPTION (provided by applicant): Funding of this application will move a new combination cancer therapy for leukemia and lymphomas towards human clinical trials. Monoclonal antibodies, mAbs have emerged as a rapidly growing class of oncology therapeutics. Despite their success in certain clinical applications, the therapeutic efficacy of mAbs is limited, with only a minority of patients resp ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
EGF/Gastrin for Islet Regeneration
SBC: PHARMAIN CORPORATION Topic: NIDDKDESCRIPTION (provided by applicant): New therapies are desperately needed to relieve patients with Type 1 diabetes from the neuropathy, nephropathy and retinopathy associated with the current standard of treatment, injected insulin. Transplantation of pancreatic islet -cells, in combination with immunosuppressant to avoid immune rejection, is restricted to a subgroup of diabetics and is limited b ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
SBIR TOPIC 255: CGMP MANUFACTURE OF NOVEL HER2/NEU EXPRESSING ADENVIRUS FOR TREAT
SBC: Etubics Corporation Topic: NCINot Available
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Autologous HIV-1 resistant T cells through accelerated CCR5 gene disruption
SBC: PRECISION GENOME ENGINEERING, INC. Topic: NIGMSDESCRIPTION (provided by applicant): Treating patients infected with Human Immunodeficiency Virus-1 (HIV-1) is a substantial clinical challenge with evolving pharmaceutical drug and dosing options. Treatments should improve the health and quality of life for HIV-infected individuals by reducing viremia and preserving immunological function. Currents therapeutic approaches utilize combination antir ...
STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Phase II of VerOFy: A New Tool to Improve Productivity for Stress Research
SBC: OASIS DIAGNOSTICS CORPORATION Topic: NCCAMDESCRIPTION (provided by applicant): This Phase II SBIR builds upon the activities of R43-AT006634, VerOFy: A New Tool to Improve Productivity and Reduce Costs for Stress Research . Technology for an integrated sample collection system was developed whichnon-invasively measures salivary cortisol levels within minutes of sample collection; this is a substantial improvement over traditional immunoa ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Monodispersed magnetic nanoparticles for improved diagnostic imaging. Phase II: S
SBC: LODESPIN LABS, LLC Topic: NIBIBDESCRIPTION (provided by applicant): In the proposed phase II NIH STTR funding opportunity (PA-12-089), LodeSpin Labs (LSL) is developing a magnetic nanoparticle tracer for use in Magnetic Particle Imaging (MPI), a disruptive new medical imaging technologycurrently being developed as a safe, effective and quantitative alternative to existing cardiac imaging technologies like CT and MRI. MPI is a p ...
STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Smart Polymer Reagents for Sensitivity and Speed-enhanced Clinical Diagnostics
SBC: NEXGENIA, INC. Topic: NIGMSDESCRIPTION (provided by applicant): Magnetic beads have gained increasing use as a convenient separation technique for many forms of cell, nucleic acid and protein isolations and analyses. In particular, the manufacturers of clinical immunoassays utilizemagnetic beads both as a solid support for antibodies specifically targeted to analytes of clinical importance, and as the separation means to is ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health